197 related articles for article (PubMed ID: 20883728)
1. Oligopeptidase B deficient mutants of Leishmania major.
Munday JC; McLuskey K; Brown E; Coombs GH; Mottram JC
Mol Biochem Parasitol; 2011 Jan; 175(1):49-57. PubMed ID: 20883728
[TBL] [Abstract][Full Text] [Related]
2. Characterization of
Barbosa GR; Marana SR; Stolf BS
Parasitology; 2022 Sep; 149(11):1411-1418. PubMed ID: 35703092
[No Abstract] [Full Text] [Related]
3. Oligopeptidase B, a missing enzyme in mammals and a potential drug target for trypanosomatid diseases.
Motta FN; Azevedo CDS; Neves BP; Araújo CN; Grellier P; Santana JM; Bastos IMD
Biochimie; 2019 Dec; 167():207-216. PubMed ID: 31628976
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma brucei brucei oligopeptidase B null mutants display increased prolyl oligopeptidase-like activity.
Kangethe RT; Boulangé AF; Coustou V; Baltz T; Coetzer TH
Mol Biochem Parasitol; 2012; 182(1-2):7-16. PubMed ID: 22123425
[TBL] [Abstract][Full Text] [Related]
5. SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.
Davenport BJ; Martin CG; Beverley SM; Orlicky DJ; Vazquez-Torres A; Morrison TE
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006921. PubMed ID: 30372439
[TBL] [Abstract][Full Text] [Related]
6. Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.
Eschenlauer SC; Faria MS; Morrison LS; Bland N; Ribeiro-Gomes FL; DosReis GA; Coombs GH; Lima AP; Mottram JC
Cell Microbiol; 2009 Jan; 11(1):106-20. PubMed ID: 19016791
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Leishmania major oligopeptidase B gives insight into the enzymatic properties of a trypanosomatid virulence factor.
McLuskey K; Paterson NG; Bland ND; Isaacs NW; Mottram JC
J Biol Chem; 2010 Dec; 285(50):39249-59. PubMed ID: 20926390
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of stage-specific aminotransferases from trypanosomatids.
Marciano D; Maugeri DA; Cazzulo JJ; Nowicki C
Mol Biochem Parasitol; 2009 Aug; 166(2):172-82. PubMed ID: 19443056
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major CorA-like magnesium transporters play a critical role in parasite development and virulence.
Zhu Y; Davis A; Smith BJ; Curtis J; Handman E
Int J Parasitol; 2009 May; 39(6):713-23. PubMed ID: 19136005
[TBL] [Abstract][Full Text] [Related]
10. Ascorbate-Dependent Peroxidase (APX) from Leishmania amazonensis Is a Reactive Oxygen Species-Induced Essential Enzyme That Regulates Virulence.
Xiang L; Laranjeira-Silva MF; Maeda FY; Hauzel J; Andrews NW; Mittra B
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527128
[TBL] [Abstract][Full Text] [Related]
11. Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).
Joshi PB; Sacks DL; Modi G; McMaster WR
Mol Microbiol; 1998 Feb; 27(3):519-30. PubMed ID: 9489664
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major methionine sulfoxide reductase A is required for resistance to oxidative stress and efficient replication in macrophages.
Sansom FM; Tang L; Ralton JE; Saunders EC; Naderer T; McConville MJ
PLoS One; 2013; 8(2):e56064. PubMed ID: 23437085
[TBL] [Abstract][Full Text] [Related]
13. Loss of virulence in NAD(P)H cytochrome b5 oxidoreductase deficient Leishmania major.
Mukherjee A; Adhikari A; Das P; Biswas S; Mukherjee S; Adak S
Biochem Biophys Res Commun; 2018 Sep; 503(1):371-377. PubMed ID: 29906460
[TBL] [Abstract][Full Text] [Related]
14. The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion.
Swenerton RK; Zhang S; Sajid M; Medzihradszky KF; Craik CS; Kelly BL; McKerrow JH
J Biol Chem; 2011 Jan; 286(1):429-40. PubMed ID: 20961853
[TBL] [Abstract][Full Text] [Related]
15.
Semini G; Paape D; Blume M; Sernee MF; Peres-Alonso D; Calvignac-Spencer S; Döllinger J; Jehle S; Saunders E; McConville MJ; Aebischer T
mBio; 2020 Jun; 11(3):. PubMed ID: 32487758
[No Abstract] [Full Text] [Related]
16. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
[TBL] [Abstract][Full Text] [Related]
17. The LPG1 gene family of Leishmania major.
Zhang K; Barron T; Turco SJ; Beverley SM
Mol Biochem Parasitol; 2004 Jul; 136(1):11-23. PubMed ID: 15138063
[TBL] [Abstract][Full Text] [Related]
18. Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity.
Madeira da Silva L; Beverley SM
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11965-70. PubMed ID: 20551225
[TBL] [Abstract][Full Text] [Related]
19. Oligopeptidase B and B2: comparative modelling and virtual screening as searching tools for new antileishmanial compounds.
Sodero AC; Dos Santos AC; Mello JF; DE Jesus JB; DE Souza AM; Rodrigues MI; DE Simone SG; Rodrigues CR; DE Matos Guedes HL
Parasitology; 2017 Apr; 144(4):536-545. PubMed ID: 28031079
[TBL] [Abstract][Full Text] [Related]
20. Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model.
de Matos Guedes HL; Duarte Carneiro MP; de Oliveira Gomes DC; Rossi-Bergmann B; Giovanni De-Simone S
Parasitol Res; 2007 Sep; 101(4):865-75. PubMed ID: 18074461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
